 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
NanoCyte Inc., Founded in August 2000, is a biotechnology start-up, developing an Immediate Release (IR) transdermal drug delivery platform technology. NanoCyte Ltd., a fully owned subsidiary is located in Israel, by the Sea of Galilee. NanoCyte is leveraging marine extracted nano-injectors formulated with therapeutic compounds. The outcome is a topical formulation, penetrating the skin within a fraction of a second, and actively delivering the drug into the epidermis skin layer. Initial target therapeutic indications include local anesthesia, psoriasis, skin cancer, and erectile dysfunction. NanoCyte offers a breakthrough in drug delivery technology. Advantages include: |
Immediate intra-dermis delivery